Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5361_Библиотеки_им_академика_М_И_Перельмана.pdf
102
unique properties such as high surface area-to-volume ratio, high surface reactivity,
high absorption capacity, abundance of surface-activated functional groups, and
better thermal stabilities [117]. Despite the proven benets of NMs, one cannot
ignore their associated risks, regulation, and management after shelf-life. It is
always recommended to employ nanotechnology with a balanced perception with
respect to environmental health and public safety [118–120].
A. Chakraborty et al.
3.7.1 Advantages ofNanobiosensors
Response time, i.e. how quickly the sensor can detect a change in signal, is an
important parameter for any efcient biosensors. A high surface-to-volume ratio
and high reactivity of nanomaterials are major factors behind the fast response time
of the nanobiosensors. Also, these along with high adsorption property of nanomaterials used in the transducers, the nanobiosensors show high permeability to analytes resulting in fast response time compared to conventional techniques and are
capable to provide instantaneous results.
The application of NMs has enabled the attainment of high levels of signal resolution and such sensors are projected to provide better signal-to-noise ratio.
Nanomaterials provide extremely high surface area/volume ratio which makes them
gain more sensitivity for the detection of a single molecule or atom or chemical
molecules even at trace level. The ultrahigh surface-to-volume ratios of nanostructures render them with extraordinary electric properties. Such sensors can be
extremely sensitive to detect any surface-adsorbed species.
Nanosensors are extremely small devices capable of detecting and responding to
a wide array of analytes. Their very small size, reliable and highly sensitive nature
provides researchers with a lab-on-chip ready for real-time analysis of several clinical procedures. Nanosensing techniques with smaller footprint that are highly portable are gaining popularity both in researcher and consumer levels, encouraging
more consumer products based on nanobiosensing being available in market.
Nanobiosensors are highly selective for their respective analytes, as they are able
to selectively detect the analyte of desire from complex media with presence of
other interfering substances. Combining analyte-specic receptor molecules on the
surface of nanotransducers (e.g. enzymes, antibodies) ensure the effective selectivity in nanobiosensors.
3.7.2 Limitations ofNanobiosensors
Recent manufacturing progresses have made possible fabrication of NMs of different properties, sizes and shapes. Their endless possibility to combine with wide
range of bio-selective ligands helps in developing highly sensitive and selective
detection systems. Though the overall nanobiosensing technique provides great
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
103
[8, 25]
[8, 25]
Graphene-quantum dots, CNT, silver
iron/zinc oxide
AuNP [25, 105]
nanoparticles
[25]
Silver nanoclusters, MB1, MB2, hairpin
oligonucleotide probes
[25]
nanoparticles on bare gold electrode,
2
Carbon nanotubes [25, 107]
nanocomposites
TiO
[25]
[25]
GCE
(continued)
109]
Fluorescein, rhodamine 6G [25, 108,
(cadmium sulphide), reduced GO-based
CNT
Enzymatic sensors, electrochemical,
Electrochemical, uorescent,
Electrochemical, uorescent Ferrocene, gold, silver, platinum, silica/
Inammatory
disease Biomarker(s) Types of nanobiosensor used Nanomaterial present References
1 Type II diabetes Blood glucose/ketone
Sl
no.
Table 3.1 Use of nanobiosensors for diagnosing inammatory diseases of human
Fluorescent, electrochemical,
APOe-4, amyloid beta,
bodies/free fatty acids,
vaspin
2 Alzheimer’s
ELISA or RIA-based immunosensors,
aptamer-based, or voltametric
immunosensors
IL-6, TNF-alpha, IL-1beta,
alpha-1 antitrypsin,
acetylcholine
disease
3 Myocardial
Electrochemical EGO, gold nanowires, SPCE [25, 106]
electrochemical, uorescent
nanosensors, nano aptasensors
C-reactive protein,
Nt-pro-BNP
infarction
4 Parkinson’s disease Alpha-synuclein, miR-195,
immunosensors
CXCL10, TNF a, TGF-b,
dopamine, homovanilic acid
5 Multiple sclerosis IgG index, IL-23, IL-17,
Nanocantilever
ELISA-RIA-based immunosensor,
amperometric, electrochemical
IL-6, IL-8, TNF-alpha,
NY-ESO-1, VOC
N, NGRN; MMP-9
IL-1beta, C cvrwer65567-
reactive protein, cTnI
diseases
7 Cardiovascular
6 Melanoma RNA of cancer cells,
uorescent nanosensors
9 Gastric cancer miR-106a and let-7a Electrochemical AuNP and CdSe (cadmium selenide) CdS
8 Lung cancer miRNA-182 Electrochemical, immunosensors MoS2/Ti3C2 nanohybrids and modied
10 Liver cancer AFP/CEA Electrochemical; immunosensors,
104
A. Chakraborty et al.
[25, 110,
111]
[25, 112]
Surface ligated Ga-Au encapsulated
mesoporous silica, SPIOS, USPIOS,
PNT-modied PGE
nanostructured PANI/GO and AuNR;
ssDNA probe (BRCA1)/PANHS/MWCNT/
GCE
Aptamer-based nanomaterials [112, 113]
cc AuNPs [113]
[8, 114]
/Au nanoparticles, core shell
4
O
2
nanoparticles/silica nanoparticles
11-MUA on Au electrode surface [115, 116]
Fe
Graphene, ZnO [115]
Inammatory
disease Biomarker(s) Types of nanobiosensor used Nanomaterial present References
Sl
no.
Table 3.1 (continued)
Nano immunosensor, magneto-
nanosensor, amperometric sandwich-
type immunosensor
Electrochemical; cyclic voltammetry AuNP-grafted functionalized graphene and
TMPRSS2-ETS
11 Prostate cancer PSA, PCA-3,
12 Breast cancer HER-2, miR-155, BRCA1,
BRCA2, ING-1, NY-BR-1,
B7-H4
Aptamer-based sensors, QCM
biosensors
Immunosensor and electrochemical
sensors
Graphene-based, electrochemical,
cyclic voltametric nanosensors
Immunosensors, electrochemical
sensors
CA 549, CASA, MCA,
MOV-1, TAG 72, B7-H4
HPV DNA
KRAS, CEA, EGF, MLH1,
VIM, SEPT9, PI3K
13 Ovarian cancer CA125, HCG, p53, CEA,
14 Cervical cancer CEA, SCC Ag, CA19-9,
15 Colorectal cancer CpG islands of APC, BRAF,
Graphene-based nanoimmunosensors,
neutrophil-derived enzymes
Immobilized anti-cyclic
16 Periodontitis ODAM, MMP-8, monocyte/
17 Arthritis and
nanorod-based sensors
citrullinated peptide
rheumatoid
arthritis
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
105
benet-cost ratio, development cost of certain nanomaterials is extremely high,
many industries still prefer traditional biosensing platforms and thus, nanomedicine
also struggles to reach out to the outskirts and rural areas [121]. Nanobiosensors are
often highly sensitive to different non-target species in analyte solution due to
unique surface properties of nanomaterials, often leading to generation of false signals. It sometimes becomes absolutely essential to prepare the analytical sample
following rigorous steps for proper purication of target analytes.
Due to their more recent development, most nanobiosensors are not extensively
calibrated against a wide range of analytical species, which makes them not cent per
cent error-free sometimes. Most nanobiosensors are fabricated as to be used once
and then disposed of. This single-use approach in many cases does elevate the cost
as well as poses an environmental risk as well. In-vivo use of nanobiosensors often
opens the door for nanotoxicity as several nanomaterials may be associated with
unknown toxicity proles which will eventually show up with prolonged use.
3.8 Conclusion andFuture Direction
Considering the comparative efcacy of conventional biosensors and nanobiosensors, it is evident that nanobiosensors can provide better sensing ability in the presence of analytes at ultra-low concentrations. Moreover, nanobiosensor technology
particularly seems to be the only option in diagnosing complicated human diseases
wherein collection and availability of samples is a tough task to meet. Recently
employed nanospheres, nanoowers, nanorods, nanotubes, nanoscaffolds alongside
structurally diverse nanoparticles and composites have been found to be extremely
useful in designing the appropriate nanobioconjugates with enzymes and/or antibodies for achieving high degree of accuracy in sensing. However, limited availability of the characterization devices, production cost and infrastructural
requirements are the major setbacks to be overcome in the near future.
Acknowledgement SM acknowledges the University Grants Commission (UGC) (Ref no.
F.2-12/2019) (STRIDE) and KNU-UGC STRIDE (Ref no. KNU/R/STRIDE/1077/21) and
Department of Science and Technology-Science & Engineering Research Board (DST-SERB)
(Ref no. SRG/2021/002605) for supporting his research activities and his research laboratory
through awarding research projects.
References
1. GBD 2016 Causes of Death Collaborators.: Global, regional, and national age-sex specic
mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of
Disease Study. Lancet. 390, 1151–1210 (2017).
2. Bennett, J.M., Reeves, G., Billman, G.E., Sturmberg, J.P.: Inammation-Nature’s Way
to Efciently Respond to All Types of Challenges: Implications for Understanding and
Managing “the Epidemic” of Chronic Diseases. Front. Med. 5, 316 (2018).
106
3. Hotamisligil, GS.: Inammation, metaammation and immunometabolic disorders. Nature.
542, 177–185 (2017).
4. Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., Agrò,
F.E.: COVID-19 diagnosis and management: a comprehensive review. J. Intern. Med. 288,
192–206 (2020).
5. Singh, S., Dhanjal, D.S., Sonali, Thotapalli, S., Kumar, V.B., Datta, S., Kumar, V., Kumar, M.,
Singh, J.An insight in bacteriophage-based biosensors with focus on their detection methods
and recent advancements. Environmental Technology and Innovation. 20, 101081 (2020).
6. Morais, A.L., Rijo, P., Hernán, M.B.B., Nicolai, M.: Biomolecules and Electrochemical Tools
in Chronic Non-Communicable Disease Surveillance: A Systematic Review. Biosensors. 10,
121 (2020).
7. Prasad, S.: Nanobiosensors: the future for diagnosis of disease?. Nanobiosensors in Disease
Diagnosis. 3, 1–10 (2014).
8. Kerry, R.G., Ukhurebor, K.E., Kumari, S., Maurya, G.K., Patra, S., Panigrahi, B., Majhi, S.,
Rout, J.R., Rodriguez-Torres, M.P., Das, G., Shinj, H.S., Patra, J.K.: A comprehensive review
on the applications of nano-biosensor-based approaches for noncommunicable and communicable disease detection. Chem. Sci. 9, 3576–3602 (2021).
9. Zheng, G., Patolsky, F., Cui, Y., Wang, W.U., Lieber, C.M.: Multiplexed electrical detection
of cancer markers with nanowire sensor arrays. Nat Biotechnol. 23, 1294–1301 (2005).
10. Metkar, S.K., Girigoswami, K.: Diagnostic biosensors inmedicine—a review. Biocatal.
Agric. Biotechnol. 17, 271–283 (2019).
11. Ukhurebor, K.E.: The Role of Biosensor in Climate Smart Organic Agriculture toward
Agricultural and Environmental Sustainability. In: Meena, R. S., editor. Agrometeorology
[Internet]. London: IntechOpen; https://doi.org/10.5772/intechopen.93150 (2020).
12. Damborský, P., Švitel, J., Katrlík, J.: Optical biosensors. Essays Biochem. 60, 91–100 (2016).
13. Sode, K., Yamazaki, T., Lee, I., Hanashia, T., Tsugawaa, W.: BioCapacitor: A novel principle
for biosensors. Biosensors and Bioelectronics. 76, 20–28 (2016).
14. Majdinasab, M., Mishra, R.K., Tang, X., Marty, J.L.: Detection of antibiotics in food: New
achievements in the development of biosensors. Trends. Analyt. Chem. 127, 115883 (2020).
15. Khan, M.Z.H., Hasan, M.R., Hossain, S.I., Ahommed, M.S., Daizy, M.: Ultrasensitive
detection of pathogenic viruses with electrochemical biosensor: State of the art. Biosens
Bioelectron. 166, 112431 (2020).
16. Ghorbani, F., Abbaszadeh, H., Mehdizadeh, A., Ebrahimi-Warkiani, M., Rashidi, M.R.,
Youse, M.: Biosensors and nanobiosensors for rapid detection of autoimmune diseases: a
review. Microchimica Acta. 186, 838 (2019).
17. Gatebe, E.: Nanotechnology: the magic bullet towards attainment of Kenya’s Vision 2030 on
industrialization. Journal of Agriculture, Science and Technology. 14, 2012 (2012).
18. Murphy, L.: Biosensors and bioelectrochemistry. Curr. Opin. Chem. Biol. 10, 177–184 (2006).
19. Padma S, Dey S, Banerjee M, Modak BK, Mukherjee S.Nanomaterials in bioprocessing and
their biomedical applications: an update. Nanomaterials for Bioreactors and Bioprocessing
Applications. Elsevier; 2023;365–401.
20. Jianrong, C., Yuqing, M., Nongyue, H., Xiaohua, W., Sijiao, L.: Nanotechnology and biosensors. Biotechnol. Adv. 22, 505–518 (2004).
21. Mokhtarzadeh, A., Eivazzadeh-Keihan, R., Pashazadeh, P., Hejazi, M., Gharaatifar, N.,
Hasanzadeh, M., Baradaran, B., de la Guardia, M.: Nanomaterial-based biosensors for detection of pathogenic virus. Trends. Analyt. Chem. 97, 445–457 (2017).
22. Kaushik, A., Mujawar, M.: Point of care sensing devices: better care for everyone. Sensors.
18, 4303 (2018).
23. Zhang, X., Guo, Q., Cui, D.: Recent advances in nanotechnology applied to biosensors.
Sensors. 9, 1033–1053 (2009).
24. Malik, P., Katyal, V., Malik, V., Asatkar, A., Inwati, G., Mukherjee, T.K.: Nanobiosensors:
Concepts and Variations. ISRN.Nanomater. 2013, 327435 (2013).
A. Chakraborty et al.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
25. Mukherjee, S., Mukherjee, N.: Current Developments in Diagnostic Biosensor Technology:
Relevance to Therapeutic Intervention of Infectious and Inammatory Diseases of Human.
In: Dutta, G., Biswas, A., Chakrabarti, A. (Eds) Modern Techniques in Biosensors. Studies
in Systems, Decision and Control, 327, (pp 1–36). Springer, Singapore. https://doi.
org/10.1007/978- 981- 15- 9612- 4_1 (2021).
26. Sposito, A.J., Kurdekar, A., Zhao, J., Hewlett, I.: Application of nanotechnology in biosensors
for enhancing pathogen detection. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnology.
10, e1512 (2018).
27. Malhotra, B.D., Ali, M.A.: Nanomaterials in Biosensors. In Nanomaterials for Biosensors
(pp.1–74). Elsevier. https://doi.org/10.1016/B978- 0- 323- 44923- 6.00001- 7 (2018).
28. Pokropivny, V., Skorokhod, V.: Classication of nanostructures by dimensionality and
concept of surface forms engineering in nanomaterial science. Mater. Sci. Eng. C. 27,
990–993 (2007).
29. Pandit, S., Dasgupta, D., Dewan, N., Ahmed, P.: Nanotechnology based biosensors and its
application. J.Pharm. Innov., 5, 18–25 (2016).
30. Das, N.C., Roy, B., Patra, R., Choudhury, A., Ghosh, M., Mukherjee, S. (2021). Surfacemodied noble metal nanoparticles as antimicrobial agents: biochemical, molecular and
therapeutic perspectives. J Photochem Photobiol B. 2021:165–205.
31. Mukherjee S, Basak B, Bhunia B, Dey A, Mondal B. Potential use of polyphenol oxidases
(PPO) in the bioremediation of phenolic contaminants containing industrial wastewater. Rev
Environ Sci Biotechnol. 2013;1(1):61–73.
32. Dey B, Mukherjee S, Mukherjee N, Mondal RK, Satpati B, Senapati D, Sinha Babu SP.Green
silver nanoparticles for drug transport, bioactivities and a bacterium (Bacillus subtilis)-mediated comparative nano-patterning feature. RSC Adv. 2016;6(52): 46573–46581.
33. Bai, Y., Xu, T., Zhang, X.: Graphene-Based Biosensors for Detection of Biomarkers.
Micromachines. 11, 60 (2020).
34. Mondal MK, Mukherjee S, Joardar N, Roy D, Chowdhury P, Sinha Babu SP. Synthesis of
smart graphene quantum dots: a benign biomaterial for prominent intracellular imaging and
improvement of drug efcacy. Appl Surf Sci. 2019;495.
35. Ganesan, M., Nagaraaj, P.: Quantum dots as nanosensors for detection of toxics: a literature
review. Anal. Methods 12, 4254–4275 (2020).
36. Sang, S., Wang, Y., Feng, Q., Wei, Y., Ji, J., Zhang, W.: Progress of new label-free techniques
for biosensors: a review. Crit. Rev. Biotechnol. 36, 465–481 (2016).
37. Bard, A.J., Parsons, R., & Jordan, J. Standard Potentials in Aqueous Solution (1st ed.).
Routledge. (2017). https://doi.org/10.1201/9780203738764.
38. Cho, I.H., Kim, D.H., Park, S.: Electrochemical biosensors: perspective on functional nanomaterials for on-site analysis. Biomater. Res. 24, 6 (2020).
39. Yin, N., Xing, Z., He, K., & Zhang, Z. (2023). Tribo-informatics approaches in tribology
research: A review. Friction, 11(1), 1–22. https://doi.org/10.1007/s40544- 022- 0596- 7.
40. Bhushan, B., Israelachvili, J. N., & Landman, U. (1995). Nanotribology: friction,
wear and lubrication at the atomic scale. Nature, 374(6523), 607–616. https://doi.
org/10.1038/374607a0.
41. Byron, S. A., Van Keuren-Jensen, K. R., Engelthaler, D. M., Carpten, J. D., & Craig,
D.W. (2016). Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nature Reviews Genetics, 17(5), 257–271. https://doi.org/10.1038/nrg.2016.10.
42. Malik, P., Katyal, V., Malik, V., Asatkar, A., Inwati, G., & Mukherjee, T. K. (2013).
Nanobiosensors: Concepts and Variations. ISRN Nanomaterials, 2013, 1–9. https://doi.
org/10.1155/2013/327435.
43. Ngowi, E.E., Wang, Y.-Z., Qian, L., Helmy, Y. A. S. H., Anyomi, B., Li, T., Zheng, M.,
Jiang, E.-S., Duan, S.-F., Wei, J.-S., Wu, D.-D., & Ji, X.-Y. (2021). The Application of
Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders. Frontiers
in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.629832.
44. Liu W, Qiao X, Liu S, Chen P.A review of nanomaterials with different dimensions as lubricant additives. Nanomaterials (Basel). 2022;12(21):3780.
107
108
45. Bhushan B.Nanotribology and nanomechanics of MEMS/NEMS and BioMEMS/BioNEMS
materials and devices. 2007;84(3):387–412.
46. Chen X, Li J.Superlubricity of carbon nanostructures. Carbon. 2020;158:1–23.
47. Zhai WZ, Zhou K.Nanomaterials in superlubricity. Adv. Funct. Mater. 2019;29.
48. Ren X, Yang X, Xie G, He F, Wang R, Zhang C, Guo D, Luo J.Superlubricity under ultrahigh
contact pressure enabled by partially oxidized black phosphorus nanosheets. npj 2D Mater
Appl 2021;44.
49. Berman D, Deshmukh SA, Sankaranarayanan SK, Erdemir A, Sumant AV.Friction. Macroscale
superlubricity enabled by graphene nanoscroll formation. Science. 2015;348(6239):1118–22.
50. Chen Z, Liu Y, Luo J.Superlubricity of nanodiamonds glycerol colloidal solution between
steel surfaces. Colloids Surf A Physicochem Eng Asp. 2016;489:400–406.
51. Moschetto S, Bolognesi M, Prescimone F, et al. Large-area oxidized phosphorene nanoakes obtained by electrospray for energy-harvesting applications. ACS Appl Nano Mater.
2021;4(4):3476–3485.
52. Vigneshvar, S., Sudhakumari, C.C., Senthilkumaran, B., Prakash, H.: Recent Advances in
Biosensor Technology for Potential Applications– An Overview. Front. Bioeng. Biotechnol.
4, 11 (2016).
53. Hutter, E., Maysinger, D.: Gold-nanoparticle-based biosensors for detection of enzyme activity. Trends. Pharmacol. Sci. 34, 497–507 (2013).
54. Kwon, S.J., Bard, A.J.: DNA analysis by application of Pt nanoparticle electrochemical
amplication with single label response. J.Am. Chem. Soc. 134, 10777–10779 (2012) 36.
55. Bohunicky, B., Mousa, S.: Biosensors: the new wave in cancer diagnosis nanotechnology.
Sci. Appl. 4, 1–10 (2011).
56. Moghadam, F.M., Rahaie, M.: A signal-on nanobiosensor for VEGF165 detection based on
supraparticle copper nanoclusters formed on bivalent aptamer. Biosensors and Bioelectronics.
132, 186–195 (2019).
57. Shi, J., Xiao, Z., Kamaly, N., Farokhzad, O.C.: Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc. Chem. Res. 44, 1123–1134 (2011).
58. Zrazhevskiy, P., Sena, M., Gao, X.: Designing multifunctional quantum dots for bioimaging,
detection, and drug delivery. Chem. Soc. Rev. 39, 4326–4354 (2010) 40.
59. Malhotra, R., Papadimitrakopoulos, F., Rusling, J.F.: Sequential layer analysis of protein immunosensors based on single wall carbon nanotube forests. Langmuir. 26,
15050–15056 (2010).
60. Zhang, L., Shay, J.W.: Multiple Roles of APC and its Therapeutic Implications in Colorectal
Cancer. J.Natl. Cancer Inst. 109, djw332 (2017).
61. Dadmehr, M., Hosseini, M., Hosseinkhani, S., Ganjali, M.R., Khoobi, M., Behzadi, H.,
Hamedani, M., Sheikhnejad, R.: DNA methylation detection by a novel uorimetric nanobiosensor for early cancer diagnosis. Biosens Bioelectron. 60, 35–44 (2014).
62. Chung, S., Chandra, P., Koo, J.P., Shim, Y.B.: Development of a bifunctional nanobiosensor for screening and detection of chemokine ligand in colorectal cancer cell line. Biosens
Bioelectron. 100, 396–403 (2018).
63. Chen, C., Peng, J., Xia, H.S., Yang, G.F., Wu, Q.S., Chen, L.D., Zeng, L.B., Zhang, Z.L.,
Pang, D.W., Li, Y.: Quantum dots-based immunouorescence technology for the quantitative
determination of HER2 expression in breast cancer. Biomaterials. 30, 2912–2918 (2009).
64. Copland, J.A., Eghtedari, M., Popov, V.L., Kotov, N., Mamedova, N., Motamedi, M.,
Oraevsky, A.A.: Bioconjugated gold nanoparticles as a molecular based contrast agent:
implications for imaging of deep tumors using optoacoustic tomography. Mol. Imaging. Biol.
6, 341–349 (2004).
65. Shahbazi, N., Zare-Dorabei, R., Naghib, S.M.: Design of a Ratiometric Plasmonic Biosensor
for Herceptin Detection in HER2-Positive Breast Cancer. C.S. Biomater. Sci. Eng. 8,
871–879 (2022).
66. Salahandish, R., Ghaffarinejad, A., Naghib, S.M., Majidzadeh-A, K., Zargartalebi, H.,
Sanati-Nezhad, A.: Nano-biosensor for Highly Sensitive Detection of HER2 Positive Breast
Cancer. Biosensors & Bioelectronics. 117, 104–111 (2018).
A. Chakraborty et al.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
67. Yang, L., Mao, H., Cao, Z., Wang, Y.A., Peng, X., Wang, X., Sajja, H.K., Wang, L., Duan,
H., Ni, C., Staley, C.A., Wood, W.C., Gao, X., Nie, S.: Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology. 136,
1514–1525 (2009).
68. Eck, W., Craig, G., Sigdel, A., Ritter, G., Old, L.J., Tang, L., Brennan, M.F., Allen, P.J., Mason,
M.D.: PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted
labeling agents for human pancreatic carcinoma tissue. ACS.Nano. 2, 2263–2272 (2008).
69. Nedelcu, A.; Mocan, T.; Grapa, C.; Mocan, L.: Recent Advances in Nanoparticle-Mediated
Diagnosis and the Treatment of Pancreatic Cancer. Int. J.Mol. Sci. 22, 8060 (2021).
70. Chen, M., Wu, D., Tu, S., Yang, C., Chen, D., Xu, Y.: A novel biosensor for the ultrasensitive
detection of the lncRNA biomarker MALAT1in non-small cell lung cancer. Sci. Rep. 11,
3666 (2021).
71. Tsai, J.R., Chong, I.W., Chen, Y.H., Yang, M.J., Sheu, C.C., Chang, H.C., Hwang, J.J., Hung,
J.Y., Lin, S.R.: Differential expression prole of MAGE family in non-small-cell lung cancer.
Lung Cancer. 56, 185–192 (2007).
72. Williams, A.: Dening neurodegenerative diseases: disorders will be named after responsible
rogue proteins and their solutions. Br. Med. J.Publ. Gr. 324, 1465–1466 (2002).
73. Goldsmith, M., Abramovitz, L., Peer, D.: Precision nanomedicine in neurodegenerative diseases. ACS. Nano. 8, 1958–1965 (2014).
74. Park, S.A., Han, S.M., Kim, C.E.: New uid biomarkers tracking non-amyloid- and non-tau
pathology in Alzheimer’s disease. Exp. Mol. Med. 52, 556–568 (2020).
75. Dhiman, K., Blennow, K., Zetterberg, H., Martins, R.N., Gupta, V.B.: Cerebrospinal uid
biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis. Cell.
Mol. Life. Sci. 76, 1833–1863 (2019).
76. Nguyen, A.T., Wang, K., Hu, G., Wang, X., Miao, Z., Azevedo, J.A., Suh, E., Van Deerlin,
V.M., Choi, D., Roeder, K., Li, M., Lee, E.B.: APOE and TREM2 regulate amyloid- responsive
microglia in Alzheimer’s disease. Acta. Neuropathol. 140, 477–493 (2020).
77. Negahdary, M., Heli, H.: An electrochemical peptide-based biosensor for the Alzheimer
biomarker amyloid-β(1-42) using a microporous gold nanostructure. Mikrochim. Acta. 186,
766 (2019).
78. Chen, Q., Du, Y., Zhang, K., Liang, Z., Li, J., Yu, H., Ren, R., Feng, J., Jin, Z., Li, F.,
Sun, J., Zhou, M., He, Q., Sun, X., Zhang, H., Tian, M., Ling, D.: Tau-targeted multifunctional nanocomposite for combinational therapy of Alzheimer’s disease. ACS nano. 12,
1321–1338 (2018).
79. Yuan, M., Wang, Y., Qin, Y.X.: Promoting neuroregeneration by applying dynamic magnetic
elds to a novel nanomedicine: superparamagnetic iron oxide (SPIO)-gold nanoparticles
bounded with nerve growth factor (NGF). Nanomedicine. 14, 1337–1347 (2018).
80. Cao, Y.X., Zhou, H., Wang, J.Q.: An approach to interval-valued intuitionistic stochastic multi- criteria decision-making using set pair analysis. Int. J. Mac. Learn. Cyber. 9,
629–640 (2018).
81. Zhang, G., Xia, Y., Wan, F., Ma, K., Guo, X., Kou, L., Yin, S., Han, C., Liu, L., Huang, J.,
Xiong, N., Wang, T.: New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease.
Front. Aging. Neurosci. 10, 370 (2018).
82. Balestrino, R., Schapira, A.H.V.: Parkinson disease. Eur. J.Neurol. 27, 27–42 (2020).
83. Kim, D., Yoo, J.M., Hwang, H., Lee, J., Lee, S.H., Yun, S.P., Park, M.J., Lee, M., Choi,
S., Kwon, S.H., Lee, S., Kwon, S.H., Kim, S., Park, Y.J., Kinoshita, M., Lee, Y.H., Shin,
S., Paik, S.R., Lee, S.J., Lee, S., Hong, B.H., Ko, H.S.: Graphene quantum dots prevent
α-synucleinopathy in Parkinson’s disease. Nat Nanotechnol. 13, 812–818 (2018).
84. Seo, G., Lee, G., Kim, M.J., Baek, S.H., Choi, M., Ku, K.B., Lee, C.S., Jun, S., Park, D., Kim,
H.G., Kim, S.J., Lee, J.O., Kim, B.T., Park, E.C., Kim, S.I.: Rapid Detection of COVID-19
Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using FieldEffect Transistor-Based Biosensor. ACS.Nano. 14, 5135–5142 (2020).
109
110
85. La Spada, L., Vegni, L.: Electromagnetic Nanoparticles for Sensing and Medical Diagnostic
Applications. Materials. 11, 603 (2018).
86. Guliy, O.I., Zaitsev, B.D., Larionova, O.S., Borodina, I.A.: Virus Detection Methods and
Biosensor Technologies. Biophysics. 64, 890–897 (2019).
87. Hewa, T.M.P., Tannock, G.A., Mainwaring, D.E., Harrison, S., Fecondo, J.V.: Detection
of Inuenza A and B Viruses in Clinical Specimens Using a Quartz crystal Microbalance.
J.Virol. Methods. 162, 14–21 (2009).
88. Jahanshahi, P., Zalnezhad, E., Sekaran, S.D., Adikan, F.R.M.: Rapid immunoglobulin
M-based dengue diagnostic test using surface plasmon resonance biosensor. Sci. Rep. 4,
3851 (2014).
89. Ngo, H.T., Wang, H.N., Fales, A.M., Nicholson, B.P., Woods, C.W., Vo-Dinh, T.:
DNA Bioassay-On-Chip Using SERS Detection for Dengue Diagnosis. Analyst. 139,
5655–5659 (2014).
90. Oh, J., Yoo, S., Chang, Y.W., Lim, K., Yoo, K.H.: Carbon nanotube-based biosensor for detection hepatitis B.Curr. Appl. Phys. 9, e229–e231 (2009).
91. Shariati, M., Sadeghi, M.: Ultrasensitive DNA biosensor for hepatitis B virus detection based
on tin-doped WO (3)/In (2)O(3) heterojunction nanowire photoelectrode under laser amplication. Anal. Bioanal. Chem. 412, 5367–5377 (2020).
92. Nilsson, H.O., Mulchandani, R., Tranberg, K.G., Stenram, U., Wadström, T.: Helicobacter
species identied in human livers from patients with cholangio-and hepatocellular carcinoma. Gastroenterol. 120, 323–324 (2001) 75.
93. Mondal MK, Mukherjee S, Saha SK, Chowdhury P, Sinha Babu SP.Design and synthesis of
reduced graphene oxide based supramolecular scaffold: A benign microbial resistant network
for enzyme immobilization and cell growth. Mat Sci Eng C. 2017;75:1168–1177.
94. Cheng, D., Yu, M., Fu, F., Han, W., Li, G., Xie, J., Song, Y., Swihart, M.T., Song, E.: Dual
Recognition Strategy for Specic and Sensitive Detection of Bacteria Using Aptamer-Coated
Magnetic Beads and Antibiotic-Capped Gold Nanoclusters Anal. Chem. 88, 820–825 (2016).
95. Singh, A., Sinsinbar, G., Choudhary, M., Kumar, V., Pasricha, R., Verma, H.N., Singh, S.P.,
Arora, K.: Graphene oxide-chitosan nanocomposite based electrochemical DNA biosensor
for detection of typhoid. Sensors and Actuators. B: Chemical. 185, 675–684 (2013).
96. Rehman, A., Sarwar, Y., Raza, Z.A., Hussain, S.Z., Mustafa, T., Khan, W.S., Ghauri, M.A.,
Haque, A., Hussain, I.: Metal nanoparticle assisted polymerase chain reaction for strain typing of Salmonella Typhi. Analyst. 140, 7366–7372 (2015).
97. Torati, S.R., Reddy, V., Yoon, S.S., Kim, C.: Electrochemical biosensor for Mycobacterium
tuberculosis DNA detection based on gold nanotubes array electrode platform. Biosens.
Bioelectron. 78, 483–488 (2016).
98. Yuen, C., Liu, Q.: Optimization of Fe3O4@ Ag nanoshells in magnetic eld-enriched surfaceenhanced resonance Raman scattering for malaria diagnosis. Analyst. 138, 6494–6500 (2013).
99. Varela-Aramburu, S., Ghosh, C., Goerdeler, F., Priegue, P., Moscovitz, O., Seeberger, P.H.:
Targeting and Inhibiting Plasmodium falciparum Using Ultra-small Gold Nanoparticles.
ACS.Appl. Mater. Interfaces. 12, 43380−43387 (2020)
100. Chowdhury P, Roy B, Mukherjee N, Mukherjee S, Joardar N, Mondal MK, Roy D, Sinha
Babu SP.Chitosan biopolymer functionalized gold nanoparticles with controlled cytotoxicity
and improved antilarial efcacy. Adv Compos Hybrid Mater. 2018;577–590.
101. Pedro, G.C., Gorza, F.D.S., Da Silva, R.J., Do Nascimento, K.T.O., Medina-Llamas, J.C.,
Chávez-Guajardo, A.E., Alcaraz-Espinoza, J.J., De Melo, C.P.: A novel nucleic acid uorescent sensing platform based on nanostructured lms of intrinsically conducting polymers.
Anal. Chim. Acta. 1047, 214–224 (2019).
102. Bazaev, N.A., Masloboev, Y.P., Selishchev, S.V.: Optical methods for noninvasive blood glucose monitoring. Biomed. Eng. 45, 229–233 (2012).
103. Dong, J.X., Gao, Z.F., Zhang, Y., Li, B.L., Zhang, W., Lei, J.L., Li, N.B., Luo, H.Q.: The
pH-switchable agglomeration and dispersion behavior of uorescent Ag nanoclusters and its
applications in urea and glucose biosensing. NPG Asia Mater. 8, e335 (2016).
A. Chakraborty et al.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
104. Baek, S., Roh, J., Park, C., Kim, M.J., Shi, R., Kailasa, S.K., Park, T.J.: Cu-nanoower decorated gold nanoparticles-graphene oxide nanober as electrochemical biosensor for glucose
detection. Mater. Sci. Eng. C. 107, article 110273 (2020).
105. Khan, S., Hasan, A., Attar, F., Shari, M., Siddique, R., Mraiche, F., Falahati, M.: Gold
Nanoparticle-Based Platforms for Diagnosis and Treatment of Myocardial Infarction.
ACS.Biomater. Sci. Eng. 6, 6460–6477 (2020).
106. Aghili, Z., Nasirizadeh, N., Divsalar, A., Shoeibi, S., Yaghmaei, P.: A highly sensitive miR-195
nanobiosensor for early detection of Parkinson’s disease, Articial Cells, Nanomedicine, and
Biotechnology. 46, S32–40 (2017).
107. Kwak, J., Gallagher, M., Ozdener, M.H., Wysocki, C.J., Goldsmith, B.R., Isamah, A.,
Faranda, A., Fakharzadeh, S.S., Herlyn, M., Johnson, A.T., Preti, G.; Volatile biomarkers
from human melanoma cells. J. Chromatogr. B.Analyt. Technol. Biomed. Life Sci. 931,
90–6 (2013).
108. Piñero, F., Dirchwolf, M., Pessôa, M.G.: Biomarkers in Hepatocellular Carcinoma: Diagnosis,
Prognosis and Treatment Response Assessment. Cells. 9, 1370 (2020).
109. Tao, L., Song, C., Huo, C., Sun, Y., Zhang, C., Li, X., Yu, S., Sun, M., Jin, B., Zhang, Z., Yang,
K.; Anti-CD155 and anti-CD112 monoclonal antibodies conjugated to a uorescent mesoporous silica nanosensor encapsulating rhodamine 6G and uorescein for sensitive detection of
liver cancer cells. Analyst. 141, 4933–4940 (2016).
110. Casanova-Salas, I., Rubio-Briones, J., Fernández-Serra, A.: Jose Antonio López-Guerrero.
miRNAs as biomarkers in prostate cancer. Clin. Transl. Oncol. 14, 803–811 (2012).
111. Barani, M., Sabir, F., Rahdar, A., Arshad, R., Kyzas, G.Z.: Nanotreatment and Nanodiagnosis
of Prostate Cancer: Recent Updates. Nanomaterials (Basel). 10, 1696 (2020).
112. Simon, I., Zhuo, S., Corral, L., Diamandis, E.P., Sarno, M.J., Wolfert, R.L., Kim, N.W.:
B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for
ovarian cancer. Cancer Res. 66, 1570–1575 (2006).
113. Pareek, S., Jain, U., Bharadwaj, M., Chauhan, N.: A label free nanosensing platform for the
detection of cervical cancer through analysis of ultratrace DNA hybridization. Sensing and
Bio-Sensing Research. 33, 100444 (2021).
114. Vacante, M., Borzì, A.M., Basile, F., Biondi, A.: Biomarkers in colorectal cancer: Current
clinical utility and future perspectives. World. J.Clin. Cases. 6, 869–881 (2018).
115. Lee, B.H., Kim, S.H., Ko, Y., Park, J.C., Ji, S., Gu, M.B.: The sensitive detection of ODAM
by using sandwich-type biosensors with a cognate pair of aptamers for the early diagnosis of
periodontal disease. Biosensors and Bioelectronics. 126, 122–128 (2019).
116. Rodphukdeekul, S.; Tabata, M.; Ratanaporncharoen, C.; Takeuchi, Y.; Somboon, P.; Boonlue,
W.; Miyahara, Y.; Sriyudthsak, M.: Quantitative Assessment of Periodontal Bacteria Using a
Cell-Based Immunoassay with Functionalized Quartz Crystal Microbalance. Chemosensors.
9, 159 (2021).
117. Kaur, R., Sharma, S.K., Tripathy, S.K.: Advantages and Limitations of Environmental
Nanosensors. Advances in Nanosensors for Biological and Environmental Analysis, 119–132.
(2019). https://doi.org/10.1016/b978- 0- 12- 817456- 2.00007- 3.
118. Ray, P.C., Yu, H., Fu, P.P.: Toxicity and environmental risks of nanomaterials: challenges and
future needs. J.Environ. Sci. Health C. 27, 1–35 (2009).
119. Roduner, E.: Size matters: why nanomaterials are different. Chem. Soc. Rev. 35,
583–592 (2006).
120. Mahadevan, V., Sethuraman, S.: Nanomaterials and Nanosensors for Medical Applications.
In: Harik, V.M., Salas, M.D. (eds) Trends in Nanoscale Mechanics. ICASE/LaRC
Interdisciplinary Series in Science and Engineering. Springer, Dordrecht. 9. 207–228 (2003).
121. Padma S, Chakraborty P, Mukherjee S. Nano-biosensors for diagnosing infectious and
lifestyle-related disease of human: an update. Next-Generation Nanobiosensor Devices for
Point-Of-Care Diagnostics. Springer; 79–103.
111